Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

SMAC mimetics promote NIK-dependent inhibition of CD4+ TH17 cell differentiation.

Rizk J, Kaplinsky J, Agerholm R, Kadekar D, Ivars F, Agace WW, Wong WW, Szucs MJ, Myers SA, Carr SA, Waisman A, Bekiaris V.

Sci Signal. 2019 Aug 27;12(596). pii: eaaw3469. doi: 10.1126/scisignal.aaw3469.

PMID:
31455723
2.

Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.

Uribesalgo I, Hoffmann D, Zhang Y, Kavirayani A, Lazovic J, Berta J, Novatchkova M, Pai TP, Wimmer RA, László V, Schramek D, Karim R, Tortola L, Deswal S, Haas L, Zuber J, Szűcs M, Kuba K, Dome B, Cao Y, Haubner BJ, Penninger JM.

EMBO Mol Med. 2019 Aug;11(8):e9266. doi: 10.15252/emmm.201809266. Epub 2019 Jun 24.

3.

STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.

Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik BA, Nyirády P, Szendröi A, Szücs M, Módos O, Olah C, Székely E, Reis H, Szarvas T.

Pathol Oncol Res. 2019 Jun 27. doi: 10.1007/s12253-019-00689-y. [Epub ahead of print]

PMID:
31250373
4.

Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.

Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik B, Olah C, Krege S, Nyirády P, Szendröi A, Szücs M, Módos O, Székely E, Reis H, Szarvas T.

Urol Oncol. 2019 Apr 30. pii: S1078-1439(19)30148-6. doi: 10.1016/j.urolonc.2019.04.015. [Epub ahead of print]

PMID:
31053526
5.

[Mucosal melanoma primary and metastatic cases with urogenital localization in our department].

Szabó B, Szűcs M, Horváth A, Székely E, Pánczél G, Liszkay G, Holló P, Wikonkál N, Nyirády P.

Orv Hetil. 2019 Mar;160(10):378-385. doi: 10.1556/650.2019.31303. Hungarian.

PMID:
30829059
6.

The effects of agent hybridization on the efficacy of biological control of tansy ragwort at high elevations.

Szűcs M, Salerno PE, Teller BJ, Schaffner U, Littlefield JL, Hufbauer RA.

Evol Appl. 2018 Nov 27;12(3):470-481. doi: 10.1111/eva.12726. eCollection 2019 Mar.

7.

Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.

Stera S, Balermpas P, Blanck O, Wolff R, Wurster S, Baumann R, Szücs M, Loutfi-Krauss B, Wilhelm ML, Seifert V, Rades D, Rödel C, Dunst J, Hildebrandt G, Arnold A, Meissner M, Kähler KC.

Melanoma Res. 2019 Apr;29(2):187-195. doi: 10.1097/CMR.0000000000000542.

PMID:
30802230
8.

Hyaluronan bound mature sperm count (HB-MaSC) is a more informative indicator of fertility than conventional sperm parameters: Correlations with Body Mass Index (BMI).

Szucs M, Osvath P, Jakab A, Varga D, Varga B, Juhasz B.

Reprod Biol. 2019 Mar;19(1):38-44. doi: 10.1016/j.repbio.2019.02.002. Epub 2019 Feb 14.

9.

[Molecular subtypes and perspectives of targeted therapies in prostate cancer].

Szarvas T, Csizmarik A, Szűcs M, Nyirády P.

Orv Hetil. 2019 Feb;160(7):252-263. doi: 10.1556/650.2019.31315. Hungarian.

PMID:
30741006
10.

Prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of solid pancreatic cancer.

Bor R, Vasas B, Fábián A, Bálint A, Farkas K, Milassin Á, Czakó L, Rutka M, Molnár T, Szűcs M, Tiszlavicz L, Kaizer L, Hamar S, Szepes Z.

BMC Gastroenterol. 2019 Jan 9;19(1):6. doi: 10.1186/s12876-018-0921-9.

11.

A Curated Resource for Phosphosite-specific Signature Analysis.

Krug K, Mertins P, Zhang B, Hornbeck P, Raju R, Ahmad R, Szucs M, Mundt F, Forestier D, Jane-Valbuena J, Keshishian H, Gillette MA, Tamayo P, Mesirov JP, Jaffe JD, Carr SA, Mani DR.

Mol Cell Proteomics. 2019 Mar;18(3):576-593. doi: 10.1074/mcp.TIR118.000943. Epub 2018 Dec 18.

PMID:
30563849
12.
13.

Assessment of genetic diversity and phylogenetic relationship of Limousin herds in Hungary using microsatellite markers.

Szűcs M, Szabó F, Bán B, Józsa C, Rózsa L, Zsolnai A, Anton I.

Asian-Australas J Anim Sci. 2019 Feb;32(2):176-182. doi: 10.5713/ajas.18.0164. Epub 2018 Jul 26.

14.

Small RNA profiling in Mycobacterium tuberculosis identifies MrsI as necessary for an anticipatory iron sparing response.

Gerrick ER, Barbier T, Chase MR, Xu R, François J, Lin VH, Szucs MJ, Rock JM, Ahmad R, Tjaden B, Livny J, Fortune SM.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):6464-6469. doi: 10.1073/pnas.1718003115. Epub 2018 Jun 5.

15.

Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types.

Mead BE, Ordovas-Montanes J, Braun AP, Levy LE, Bhargava P, Szucs MJ, Ammendolia DA, MacMullan MA, Yin X, Hughes TK, Wadsworth MH 2nd, Ahmad R, Rakoff-Nahoum S, Carr SA, Langer R, Collins JJ, Shalek AK, Karp JM.

BMC Biol. 2018 Jun 5;16(1):62. doi: 10.1186/s12915-018-0527-2.

16.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O.

Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018.

17.

Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells.

Kuo HH, Ahmad R, Lee GQ, Gao C, Chen HR, Ouyang Z, Szucs MJ, Kim D, Tsibris A, Chun TW, Battivelli E, Verdin E, Rosenberg ES, Carr SA, Yu XG, Lichterfeld M.

Immunity. 2018 Jun 19;48(6):1183-1194.e5. doi: 10.1016/j.immuni.2018.04.004. Epub 2018 May 22.

18.

Following-up skin penetration of lidocaine from different vehicles by Raman spectroscopic mapping.

Bakonyi M, Gácsi A, Kovács A, Szűcs MB, Berkó S, Csányi E.

J Pharm Biomed Anal. 2018 May 30;154:1-6. doi: 10.1016/j.jpba.2018.02.056. Epub 2018 Mar 6.

PMID:
29524770
19.

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.

Bálint A, Farkas K, Szepes Z, Nagy F, Szűcs M, Tiszlavicz L, Bor R, Milassin Á, Rutka M, Fábián A, Molnár T.

BMC Gastroenterol. 2018 Jan 8;18(1):7. doi: 10.1186/s12876-017-0725-3.

20.

[Experience with cabazitaxel therapy for patients with metastatic castrate resistant prostate cancer in Hungary].

Maráz A, Boér K, Dankovics Z, Dank M, Lahm E, Petrányi Á, Révész J, Ruzsa Á, Szûcs M, Valikovics A, Vas M, Küronya Z.

Magy Onkol. 2017 Dec 18;61(4):353-360. Epub 2017 Nov 30. Hungarian.

21.

Rapid adaptive evolution in novel environments acts as an architect of population range expansion.

Szűcs M, Vahsen ML, Melbourne BA, Hoover C, Weiss-Lehman C, Hufbauer RA.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13501-13506. doi: 10.1073/pnas.1712934114. Epub 2017 Nov 28.

22.

Quantitative Proteomic Profiling Reveals Novel Plasmodium falciparum Surface Antigens and Possible Vaccine Candidates.

Nilsson Bark SK, Ahmad R, Dantzler K, Lukens AK, De Niz M, Szucs MJ, Jin X, Cotton J, Hoffmann D, Bric-Furlong E, Oomen R, Parrington M, Milner D, Neafsey DE, Carr SA, Wirth DF, Marti M.

Mol Cell Proteomics. 2018 Jan;17(1):43-60. doi: 10.1074/mcp.RA117.000076. Epub 2017 Nov 21.

23.

[Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].

Rutka M, Molnár T, Bor R, Farkas K, Fábián A, Győrfi M, Bálint A, Milassin Á, Szűcs M, Tiszlavicz L, Nagy F, Szepes Z.

Orv Hetil. 2017 Oct;158(42):1658-1667. doi: 10.1556/650.2017.30822. Hungarian.

PMID:
29037058
24.

Assessment of the Role of Everolimus Therapy in Patients with Renal Cell Carcinoma Based on Daily Routine and Recent Research Results.

Maráz A, Csejtei A, Kocsis J, Szűcs M, Kahán Z, Bodoky G, Dank M, Mangel L, Révész J, Varga Z, Géczi L.

Pathol Oncol Res. 2019 Jan;25(1):149-156. doi: 10.1007/s12253-017-0317-0. Epub 2017 Oct 13.

PMID:
29027615
25.

Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas.

Bor R, Fábián A, Bálint A, Farkas K, Szűcs M, Milassin Á, Czakó L, Rutka M, Molnár T, Szepes Z.

Therap Adv Gastroenterol. 2017 Aug;10(8):599-607. doi: 10.1177/1756283X17718408. Epub 2017 Jul 10.

26.

Analysis of risk factors - especially different types of plexitis - for postoperative relapse in Crohn's disease.

Milassin Á, Sejben A, Tiszlavicz L, Reisz Z, Lázár G, Szűcs M, Bor R, Bálint A, Rutka M, Szepes Z, Nagy F, Farkas K, Molnár T.

World J Gastrointest Surg. 2017 Jul 27;9(7):167-173. doi: 10.4240/wjgs.v9.i7.167.

27.

The power of evolutionary rescue is constrained by genetic load.

Stewart GS, Morris MR, Genis AB, Szűcs M, Melbourne BA, Tavener SJ, Hufbauer RA.

Evol Appl. 2017 May 26;10(7):731-741. doi: 10.1111/eva.12489. eCollection 2017 Aug.

28.

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.

Penke B, Fulop L, Szucs M, Frecska E.

Curr Neuropharmacol. 2018;16(1):97-116. doi: 10.2174/1570159X15666170529104323. Review.

29.

Pregnancy does not affect fecal calprotectin concentration in healthy women.

Bálint A, Berényi A, Farkas K, Pallagi Kunstár É, Altorjay Á, Csonka A, Krizsán M, Szűcs M, Pál A, Fábián A, Bor R, Milassin Á, Szulcsán Á, Mariann R, Szepes Z, Molnár T.

Turk J Gastroenterol. 2017 May;28(3):171-175. doi: 10.5152/tjg.2017.16711. Epub 2017 Mar 23.

30.

Genetic and demographic founder effects have long-term fitness consequences for colonising populations.

Szűcs M, Melbourne BA, Tuff T, Weiss-Lehman C, Hufbauer RA.

Ecol Lett. 2017 Apr;20(4):436-444. doi: 10.1111/ele.12743. Epub 2017 Feb 1.

PMID:
28145080
31.

Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival.

Niedworok C, Tschirdewahn S, Reis H, Lehmann N, Szücs M, Nyirády P, Romics I, Rübben H, Szarvas T.

Pathol Oncol Res. 2017 Jul;23(3):643-650. doi: 10.1007/s12253-016-0171-5. Epub 2016 Dec 23.

PMID:
28012116
32.

[Factors influencing early detection of malignant melanoma].

Petrovszki I, Csányi I, Szűcs M, Ócsai H, Houshmand N, Kemény L, Oláh J, Baltás E.

Orv Hetil. 2016 Dec;157(51):2028-2033. Hungarian.

PMID:
27989229
33.

Knowledge and attitudes of female university students on menstrual cycle and contraception.

Szűcs M, Bitó T, Csíkos C, Párducz Szöllősi A, Furau C, Blidaru I, Kapamadzija A, Sedlecky K, Bártfai G; Scientific Group of the collaborating centres.

J Obstet Gynaecol. 2017 Feb;37(2):210-214. doi: 10.1080/01443615.2016.1229279. Epub 2016 Dec 6.

PMID:
27923286
34.

Prospective Comparison of Magnetic Resonance Imaging, Transrectal and Transperineal Sonography, and Surgical Findings in Complicated Perianal Crohn Disease.

Bor R, Farkas K, Bálint A, Szűcs M, Ábrahám S, Milassin Á, Rutka M, Nagy F, Milassin P, Szepes Z, Molnár T.

J Ultrasound Med. 2016 Nov;35(11):2367-2372. Epub 2016 Sep 14.

PMID:
27629757
35.

Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum.

Rutka M, Bor R, Bálint A, Fábián A, Milassin Á, Nagy F, Szepes Z, Szűcs M, Tiszlavicz L, Farkas K, Molnár T.

Mediators Inflamm. 2016;2016:2492081. doi: 10.1155/2016/2492081. Epub 2016 Jun 16.

36.

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.

Szendrői A, Szász AM, Kardos M, Tőkés AM, Idan R, Szűcs M, Kulka J, Nyirády P, Szendrői M, Szállási Z, Győrffy B, Tímár J.

Oncotarget. 2016 Jul 5;7(27):42086-42098. doi: 10.18632/oncotarget.9669.

37.

[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study].

Rutka M, Bálint A, Farkas K, Palatka K, Lakner L, Miheller P, Rácz I, Hegede G, Vincze Á, Horváth G, Szabó A, Nagy F, Szepes Z, Gábor Z, Zsigmond F, Zsóri Á, Juhász M, Csontos Á, Szűcs M, Bor R, Milassin Á, Molnár T.

Orv Hetil. 2016 May 1;157(18):706-11. doi: 10.1556/650.2016.30429. Hungarian.

PMID:
27106726
38.

[Improvement of the reliability of the cause of death diagnoses by co-operation of public health authorities and the Central Statistical Office in Hungary].

Szücs M, Pintérné Grósz D, Sándor J.

Orv Hetil. 2016 Mar 27;157(13):504-11. doi: 10.1556/650.2016.30398. Hungarian.

PMID:
26996898
39.

Trends in Gastrointestinal Cancer Mortality Rate in Hungary.

Farkas K, Szűcs M, Nyári TA.

Pathol Oncol Res. 2016 Oct;22(4):681-8. doi: 10.1007/s12253-016-0052-y. Epub 2016 Mar 10.

PMID:
26965245
40.

A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.

Annaházi A, Ábrahám S, Farkas K, Rosztóczy A, Inczefi O, Földesi I, Szűcs M, Rutka M, Theodorou V, Eutamene H, Bueno L, Lázár G, Wittmann T, Molnár T, Róka R.

Br J Cancer. 2016 Mar 29;114(7):787-92. doi: 10.1038/bjc.2016.31. Epub 2016 Feb 23.

41.

[Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction].

Daróczi T, Bor R, Fábián A, Szabó E, Farkas K, Bálint A, Czakó L, Rutka M, Szűcs M, Milassin Á, Molnár T, Szepes Z.

Orv Hetil. 2016 Feb 14;157(7):268-74. doi: 10.1556/650.2016.30365. Hungarian.

PMID:
26853728
42.

Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.

Niedworok C, vom Dorp F, Tschirdewahn S, Rübben H, Reis H, Szucs M, Szarvas T.

Int Urol Nephrol. 2016 Mar;48(3):355-61. doi: 10.1007/s11255-015-1185-8. Epub 2016 Jan 2.

PMID:
26725072
43.

Reply to Wootton and Pfister: The search for general context should include synthesis with laboratory model systems.

Hufbauer RA, Szűcs M, Kasyon E, Youngberg C, Koontz MJ, Richards C, Tuff T, Melbourne BA.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E5904. doi: 10.1073/pnas.1517210112. Epub 2015 Oct 19. No abstract available.

44.

Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice.

Bálint A, Farkas K, Palatka K, Lakner L, Miheller P, Rácz I, Hegede G, Vincze Á, Horváth G, Szabó A, Nagy F, Szepes Z, Gábor Z, Zsigmond F, Zsóri Á, Juhász M, Csontos Á, Szűcs M, Bor R, Milassin Á, Rutka M, Molnár T.

J Crohns Colitis. 2016 Jan;10(1):26-30. doi: 10.1093/ecco-jcc/jjv169. Epub 2015 Sep 20.

PMID:
26392413
45.

Three types of rescue can avert extinction in a changing environment.

Hufbauer RA, Szűcs M, Kasyon E, Youngberg C, Koontz MJ, Richards C, Tuff T, Melbourne BA.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10557-62. doi: 10.1073/pnas.1504732112. Epub 2015 Aug 3.

46.

Antidepressant drugs and teenage suicide in Hungary: Time trend and seasonality analysis.

Otuyelu E, Foldvari A, Szabo E, Sipos V, Edafiogho P, Szucs M, Dome P, Rihmer Z, Sandor J.

Int J Psychiatry Clin Pract. 2015;19(3):221-5. doi: 10.3109/13651501.2015.1061017. Epub 2015 Jul 7.

PMID:
26058968
47.

[Comparison of symptoms, laboratory parameters and illness perception in patients with irritable bowel syndrome and inflammatory bowel disease].

Bor R, Balanyi Z, Farkas K, Bálint A, Rutka M, Szűcs M, Milassin Á, Szepes Z, Nagy F, Molnár T.

Orv Hetil. 2015 Jun 7;156(23):933-8. doi: 10.1556/650.2015.30168. Hungarian.

PMID:
26027601
48.

Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.

Foldvari A, Kovacs N, Sipos V, Merth G, Vincze F, Szucs M, Sandor J.

Wien Klin Wochenschr. 2015 Jun;127(11-12):459-64. doi: 10.1007/s00508-015-0796-5. Epub 2015 May 20.

PMID:
25990531
49.

Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?

Rutka M, Milassin Á, Szepes Z, SzŰcs M, Nyári T, Bálint A, Bor R, Molnár T, Farkas K.

Scand J Gastroenterol. 2015 Aug;50(8):985-90. doi: 10.3109/00365521.2015.1018313. Epub 2015 Mar 2.

PMID:
25733077
50.

The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.

Farkas K, Saródi Z, Bálint A, Földesi I, Tiszlavicz L, Szűcs M, Nyári T, Tajti J, Nagy F, Szepes Z, Bor R, Annaházi A, Róka R, Molnár T.

J Crohns Colitis. 2015 Mar;9(3):231-7. doi: 10.1093/ecco-jcc/jjv005. Epub 2015 Jan 12.

PMID:
25585596

Supplemental Content

Support Center